Scientific Program

Please find here the scientific program for the 2024 ESVONC congress in Bucharest. 

There will be no live streaming.  

The Nurses program on Friday 24th & Saturday 25th May is visible under the separate tab in the top menu.



The Grand Hotel Bucharest will be the venue for the 2024 ESVONC Congress.


Wednesday 22nd May - Residents' Workshop

Residents' Workshop
15.00-15.45 Making the grade: A review of tumor grading systems in veterinary onco-pathology for common to rare tumor types  Giancarlo Avallone 
15.45-16.30 Going above and beyond: How may an individual patient's tumor be analyzed and reported in the future? Is there such a thing as personalized pathology? Giancarlo Avallone 
16.30-17.00 COFFEE BREAK  
17.00-17.45 Targeted therapies and iNKT cells: Innovative Engineering in Human and Canine Immunotherapy to meet Ever-Emerging Challenges in Cancer Care  Nicola Mason
17.45-18.15 Targeted therapies in Cancer Management: Monoclonal antibodies and checkpoint inhibition harness immune power to eliminate cancer Nicola Mason


Thursday 23rd May - Main program

08.45-09.00 Welcome ESVONC to Bucharest! Anca Cristea

Session supported by Varian Medical Systems

09.00-09.30 Introduction and General Principles and Limitations about abdominal RT Valerie Poirier
09.30-10.15 Abdominal SBRT and hypofractionation in humans – possible implications for animal radiotherapy Nuno Pimentel MD
10.15-10.45 COFFEE BREAK  
10.45-11.15 Abdominal RT in veterinary practice : genito-urinary and other indications Michael Nolan
11.15-11.45 ASAC the Zurich Experience  Carla Rohrer 
11.45 - 12.15

PANEL DISCUSSION chaired by Dr Valerie Poirier

All speakers
12.15-14.15 Lunch & Poster Session  

Sponsored talk by Varian (TBC)

RT Abstracts
15.00-15.15 Improvement of neurodisability scores in dogs with intracranial neoplasia treated with two randomly assigned radiation protocols Felicitas Czichon
15.15-15.30 Acute toxicity associated with a daily 5-fraction stereotactic radiation therapy protocol for confirmed or MRI-presumed canine intracranial meningioma James Elliott
15.30-15.45 Preliminary insights from quantitative analysis of pituitary tumour response to definitive radiotherapy in dogs: comparison of three measurement methods Tommaso Pilla
15.45-16.00 A cyclical, palliative-intent hypofractionated radiotherapy protocol (‘Quad-shot’) for the treatment of canine nasal tumours Ines Cabral
16.00-16.30 COFFEE BREAK  
RT Abstracts
16.30-16.45 Can pre-treatment biopsy characteristics predict early treatment failure in feline nasal lymphoma treated with radiation therapy? Valerie Poirier
16.45-17.00 Comparison of two radiotherapy protocols for the palliative treatment of canine nasal adenocarcinoma delivered at a single institution Alison Hayes
17.00-17.15 Efficacy and tolerance of short cycles of palliative radiotherapy in advanced anal sac adenocarcinomas in dogs Mario Militi
17.15-17.30 Long Term Follow-up of dogs with Anal Sac Gland Carcinoma (ASGC) Receiving a Moderate Total Dose 10 Fraction Adjuvant Radiation Protocol 32-36 Gy Sarah L Mason


ESVONC CRF Committee

Welcome Reception in Bucharest!

venue: PALACE OF THE PARLIAMENT (Izvor street, no. 2-4)

kindly sponsored by

 Hill's Pet Nutrition & Volition Veterinary




Friday 24th May - Main Program



Breakfast round table DeepscanDx (TBC)

09.00-09.45 Comparative approaches to improve efficacy and availability of adoptive cell therapies for canine cancer patients Nicola Mason
09.45-10.30 The hunt for correlative biomarkers of immunotherapeutic response - knowing who will respond before treatment Nicola Mason
10.30-11.00 COFFEE BREAK  
11.00-11.45 Immune Checkpoint inhibition: The human experience and Pathways to Veterinary Applications David Vail
11.45-12.30 Novel treatments of metastatic solid tumors: from oligometastatic to polymetastatic states David Vail
12.30-13.00 PANEL DISCUSSION All speakers
13.00-14.30 Lunch  

Radiation Oncology Specialty Seminar (for ECVDI RO and ECVIM RO only): 

Machine and Patient-Specific Quality Control in Radiotherapy: Technical and Physical Aspects, and Impact on Daily Clinical Practice and Complication-Free Tumor Control

Sergejs Unterkirhers
Oral Abstracts
14.30-14.45 Tonsillar squamous cell carcinoma in 10 dogs treated with definitive-intent radiation therapy – preliminary data Ana Rejec JenĨek
14.45-15.00 Radiation therapy on macroscopic thyroid tumors: a retrospective study Carlotta Marie Ahrens
15.00-15.15 Prevalence, distribution and prognostic impact of metastatic site in canine patients affected by splenic hemangiosarcoma Chiara Catalucci
15.15-15.30 Vinorelbine for the treatment of histiocytic sarcoma: clinical response and toxicity profile in 18 dogs Nina Vigevani
15.30-16.00 COFFEE BREAK  

SPONSORED TALK by CanCan Diagnostics

Oral Abstracts
16.30-16.45 Pilot study investigating the intravenous administration of monomeric L-asparaginase to dogs with multicentric lymphoma Vittorio Botta
16.45-17.00 Electrochemotherapy for the treatment of canine prostatic carcinoma: preliminary results in nine dogs Filomena Assunta Amato
17.00-17.15 Current recommendations for sentinel lymph node biopsy in canine malignancies: a survey study Lavinia Elena Chiti
17.15-17.30 Evaluation of time to neutropenic nadir in dogs receiving carboplatin: a multicentric retrospective study Jose Alvarez Picornell
18.00-... Evening on your own!  


Saturday 25th May - Main Program

08.00-09.00 REGISTRATION  
Artificial Intelligence Lectures
09.00-09.45 Artificial Intelligence: What is AI? And what is its current and future relevance to human and veterinary biomedical sciences? Kevin Wells

AI in veterinary oncology: Tumor grading, staging and treatment

Kevin Wells
10.30-11.00 COFFEE BREAK  
11.00-11.45 Artificial intelligence in diagnostic imaging: reality or promise? Tommaso Banzato
11.45-12.30 AI in Radiation Oncology Michael Nolan
12.30-13.00 PANEL DISCUSSION chaired by Dr Nicola Mason All speakers
13.00-15.00 Lunch  

SPONSORED TALK by DeepscanDx (title TBC)

Oral Abstracts
15.30-15.45 Characterization of the fecal microbiota in dogs with mast cell tumours and comparison with healthy dogs Catarina Aluai-Cunha
15.45-16.00 Multimodal characterization of canine perivascular wall and peripheral nerve sheath tumors Houria Ech-Cherif
16.00-16.15 Looking forward to 2025 ESVONC @ PORTO Presentation  
16.15-16.45 COFFEE BREAK  
Oral Abstracts
16.45-17.00 Molecular characterization of canine FSA and MFS using spatially defined transcriptomics and proteomics Daniel Fuchs
17.00-17.15 Trametinib inhibits growth of canine oral squamous cell carcinoma Santiago Peralta
17.15-17.30 Comparison of various electrochemotherapy protocols for the treatment of feline cutaneous squamous cell carcinoma Nicolas Diop
17.30-17.45 Microwave ablation in veterinary oncology : a pilot study in 23 patients David Sayag
17.45-18.00 Comparison of MOPP versus LOPP for first-line treatment of canine multicentric T-cell or hypercalcemic lymphoma Ashley Smith



kindly sponsored by